| Influenza Vaccine Uptake Among Healthcare Workers (NCT05521763) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2022-03-12 |
| Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 (NCT05298800) | Centers for Disease Control and Prevention, China | 2021-10-08 |
| Financing Strategies of Influenza Vaccination in China (NCT04038333) | Peking University | 2019-08-01 |
| A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (NCT03734237) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2018-11-06 |
| Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children (NCT03735147) | Imperial College London | 2018-10-23 |
| Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado (NCT03246100) | University of Colorado, Denver | 2017-09-06 |
| Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute (NCT03057483) | Butantan Institute | 2017-04-06 |
| Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis (NCT02831608) | Ole Frobert, MD, PhD | 2016-10-01 |
| Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates (NCT02761551) | University of Colorado, Denver | 2016-09-01 |
| Adjuvanted Influenza Vaccine in Stem Cell Transplant (NCT02560909) | University Health Network, Toronto | 2015-10-01 |
| Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents (NCT02358083) | Indiana University | 2014-08-01 |
| MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly (NCT01623232) | US Department of Veterans Affairs | 2012-10-01 |
| Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age (NCT01310413) | GlaxoSmithKline | 2011-03-07 |
| Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children (NCT01195779) | GlaxoSmithKline | 2010-09-30 |
| Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly (NCT01013675) | Abbott Biologicals | 2009-11-01 |
| Evaluation of a School-based Influenza Vaccination Program (NCT00961337) | Centers for Disease Control, Taiwan | 2008-10-01 |
| Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years (NCT00718120) | GlaxoSmithKline | 2008-07-18 |
| A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk (NCT00586469) | GlaxoSmithKline | 2007-12-14 |
| Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults (NCT00449670) | GlaxoSmithKline | 2007-03-24 |
| Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A) (NCT00430521) | GlaxoSmithKline | 2007-02-05 |
| Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy (NCT00402805) | University Health Network, Toronto | 2006-10-01 |
| Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population (NCT00306995) | GlaxoSmithKline | 2005-05-11 |
| Memory for Flu Facts and Myths and Effects on Vaccine Intentions (NCT00296270) | University of Michigan | 2005-03-01 |
| Influenza Vaccination and Oral Anticoagulant Therapy (NCT00222638) | University Of Perugia | 2004-10-01 |